Horizon Pharma (HZNP) Tops Q3 EPS by 30c; Boosts FY15 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil prices set for weekly fall on easing fears over Saudi supply disruption
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
Mizuho Bullish on Horizon Pharma (HZNP) Into Today's Investor Day
November 9, 2015 6:51 AM ESTHorizon Pharma (NASDAQ: HZNP) is hosting its analyst day today at 11:30 and will offer short and long term guidance as it grows increasingly focused on its Orphan franchise. The analyst day will be key to drawing distinctions between Horizon's and Valeant's specialty pharma models. PBMs... More
Guggenheim Shows Increasing Confidence in Horizon Pharma (HZNP) Following 3Q Beat; Reiterates Buy
November 6, 2015 11:10 AM ESTGuggenheim reiterated a Buy rating and $40.00 price target on Horizon Pharma (NASDAQ: HZNP) following the company's 3Q15 earnings report. HZNP reported adjusted diluted 3Q15 EPS of $0.70, $0.29 above consensus. The company also raised its '15 EBITDA guidance to $350MM-$360MM from $265MM-$280MM, consensus was... More
